[go: up one dir, main page]

ECSP14000460A - Composiciones que comprenden maltotriosa y procesos para usar los mismos para inhibir el daño causado por el proceso de deshidratación - Google Patents

Composiciones que comprenden maltotriosa y procesos para usar los mismos para inhibir el daño causado por el proceso de deshidratación

Info

Publication number
ECSP14000460A
ECSP14000460A ECIEPI2014460A ECPI201400460A ECSP14000460A EC SP14000460 A ECSP14000460 A EC SP14000460A EC IEPI2014460 A ECIEPI2014460 A EC IEPI2014460A EC PI201400460 A ECPI201400460 A EC PI201400460A EC SP14000460 A ECSP14000460 A EC SP14000460A
Authority
EC
Ecuador
Prior art keywords
compositions
processes
damage caused
maltotrious
inhibit
Prior art date
Application number
ECIEPI2014460A
Other languages
English (en)
Inventor
Zihua Ao
Juan M Gonzalez
Bradley J Taylor
Original Assignee
Zaner Bloser Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46846027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP14000460(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zaner Bloser Inc filed Critical Zaner Bloser Inc
Publication of ECSP14000460A publication Critical patent/ECSP14000460A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Detergent Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

Se revelan aquí composiciones que comprenden maltotriosa. En ciertas realizaciones, las composiciones comprenden maltotriosa y al menos un componente cuyas funciones están sujetas a daños por un proceso de deshidratación, tales como un microorganismo vivo. Los procesos para inhibir el daño causado por la deshidratación son también revelados aquí. En realizaciones particulares, el proceso incluye preparar una composición que comprende maltotriosa y al menos un componente cuyas funciones
ECIEPI2014460A 2011-10-11 2014-05-09 Composiciones que comprenden maltotriosa y procesos para usar los mismos para inhibir el daño causado por el proceso de deshidratación ECSP14000460A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/270,607 US20130089638A1 (en) 2011-10-11 2011-10-11 Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes

Publications (1)

Publication Number Publication Date
ECSP14000460A true ECSP14000460A (es) 2015-06-30

Family

ID=46846027

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI2014460A ECSP14000460A (es) 2011-10-11 2014-05-09 Composiciones que comprenden maltotriosa y procesos para usar los mismos para inhibir el daño causado por el proceso de deshidratación

Country Status (16)

Country Link
US (1) US20130089638A1 (es)
EP (1) EP2765872A1 (es)
CN (2) CN103929979A (es)
AR (1) AR088035A1 (es)
BR (1) BR112014008498A2 (es)
CA (1) CA2852109A1 (es)
CO (1) CO6940418A2 (es)
EC (1) ECSP14000460A (es)
HK (2) HK1199797A1 (es)
MX (1) MX2014004060A (es)
PE (1) PE20142080A1 (es)
PH (1) PH12014500795A1 (es)
RU (1) RU2014110708A (es)
SG (1) SG11201400696XA (es)
TW (2) TW201822640A (es)
WO (1) WO2013055463A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6823601B2 (ja) 2015-10-30 2021-02-03 株式会社ヤクルト本社 微生物乾燥菌体の製造方法
EP3524051A1 (en) * 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792183A (en) * 1971-08-10 1974-02-12 Nabisco Inc Cereal coating composition and process
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
US4814267A (en) * 1984-09-18 1989-03-21 Michigan Biotechnology Institute Method for preparing high conversion syrups and other sweeteners
ATE100855T1 (de) * 1988-11-10 1994-02-15 Takeda Chemical Industries Ltd Saure urease-zubereitungen fuer alkoholische getraenke.
US5145697A (en) * 1989-04-26 1992-09-08 Mpy Foods, Inc. Instant yogurt composition and process
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
EP1961312A3 (en) 1991-01-24 2010-03-31 Martek Biosciences Corporation Microbial oil mixture and uses thereof
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
JPH09505516A (ja) 1993-11-17 1997-06-03 ニロ・ホールディング・アー／エス 凝集塊粉体を製造するための噴霧乾燥方法及び装置
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
ES2243965T3 (es) * 1996-07-09 2005-12-01 Societe Des Produits Nestle S.A. Procedimiento de secado mediante pulverizacion.
US6223455B1 (en) 1999-05-03 2001-05-01 Acusphere, Inc. Spray drying apparatus and methods of use
US6463675B1 (en) 1999-09-29 2002-10-15 Niro A/S Process and a plant for spray drying
US6322994B1 (en) * 1999-11-04 2001-11-27 Genetix Limited Method of freeze-drying organisms
EP1260227A1 (en) * 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
FR2829147B1 (fr) * 2001-08-30 2003-12-12 Agronomique Inst Nat Rech Procede de preparation d'une composition lyophilisee contenant des bacteries lactiques a viabilite et activite bacteriennes ameliorees lors d'un stockage a temperature ambiante et composition obtenue
US6838097B1 (en) * 2001-12-14 2005-01-04 Stephen Tsengas Pet food product
SI1565547T2 (sl) * 2002-06-28 2013-02-28 Biosearch S.A. Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
WO2006029467A1 (en) * 2004-09-16 2006-03-23 Btf Pty Ltd Rapid freeze drying process
EP1656930A1 (en) 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
WO2006067647A2 (en) * 2004-12-21 2006-06-29 Firmenich Sa Encapsulated polyunsaturated fatty acids
US20090065745A1 (en) * 2005-03-31 2009-03-12 Hirotsugu Kido Anti-degradation agent
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
WO2007058027A1 (ja) * 2005-11-18 2007-05-24 Idemitsu Kosan Co., Ltd. バチルス・チューリンゲンシスを含む有害菌の防除剤
JP4889317B2 (ja) * 2006-02-17 2012-03-07 オリエンタル酵母工業株式会社 マルトトリオース高含有組成物及びその製造方法
EP1903291A1 (en) 2006-09-19 2008-03-26 Ima-Telstar S.L. Method and system for controlling a freeze drying process
JP2011507518A (ja) * 2007-12-20 2011-03-10 アボット・ラボラトリーズ 安定な栄養粉末
CN102014873A (zh) * 2008-02-25 2011-04-13 诺瓦瓦克斯股份有限公司 糖玻璃化的病毒样颗粒
CN101313715A (zh) * 2008-07-09 2008-12-03 内蒙古蒙牛乳业（集团）股份有限公司 一种添加维生素适用于12到36个月的婴儿液态乳
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
BR112013003244B1 (pt) * 2010-08-13 2018-07-17 Advanced Bionutrition Corp composição seca estabilizante para material biológico, seu método de preparação, e formulação de carreamento oral

Also Published As

Publication number Publication date
US20130089638A1 (en) 2013-04-11
PH12014500795A1 (en) 2022-12-02
CA2852109A1 (en) 2013-04-18
AR088035A1 (es) 2014-05-07
WO2013055463A1 (en) 2013-04-18
EP2765872A1 (en) 2014-08-20
TW201325460A (zh) 2013-07-01
HK1199797A1 (en) 2015-07-24
CN107647394A (zh) 2018-02-02
CO6940418A2 (es) 2014-05-09
SG11201400696XA (en) 2014-08-28
BR112014008498A2 (pt) 2017-04-11
TW201822640A (zh) 2018-07-01
MX2014004060A (es) 2014-07-09
CN103929979A (zh) 2014-07-16
PE20142080A1 (es) 2014-12-24
RU2014110708A (ru) 2015-11-20
HK1250315A1 (zh) 2018-12-14

Similar Documents

Publication Publication Date Title
CR20140079A (es) Aminoquinazolinas como inhibidores de quinasa
MX2019007709A (es) Analogos de compstatina de celula reactiva, de accion prolongada u objetivos y composiciones y metodos relacionados.
CR20150277A (es) Piridina-2-amidas utiles como agonistas cb2
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
CO6620055A2 (es) Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos
AR091837A1 (es) Compuestos para inmunoterapia dirigida
CR20140166A (es) Compuestos de (hetero)arilciclopropilamina como inhibidores de lsd1
UY34051A (es) Derivados de pirrolotriazinona como inhibidores de pi3k
UY34648A (es) Amidas como inhibidores de pim
JOP20200175A1 (ar) حقنة
CR20150279A (es) Lactamas fusionadas de arilo y heteroarilo
UY35237A (es) Composiciones que comprenden un compuesto de triazol
UY35238A (es) Composiciones que comprenden un compuesto de triazol
CR20150250A (es) Nuevos derivados de piridina
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
UY34414A (es) Composiciones hemostáticas
UY33936A (es) Derivados de fluoro-piridinona útiles como agentesantibacterianos.
CR20110437A (es) Composiciones antifúngicas de polieno
UY34415A (es) Composiciones hemostáticas
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
CR20150204A (es) Nuevos derivados de piridina
ECSP11010816A (es) Nuevos Compuestos
BR112015007843A2 (pt) método para a preparação de um polímero, polímero, artigo e método de preparação de um artigo
AR078323A1 (es) Tratamiento con fampridina de liberacion sostenida en pacientes con esclerosis multiple
CO6460762A2 (es) 5-alquinil-piridinas